Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling

被引：0
|
作者：
Manoj S. Chiney
Juki Ng
John P. Gibbs
Mohamad Shebley
机构：
[1] AbbVie,Clinical Pharmacology and Pharmacometrics
来源：
Clinical Pharmacokinetics | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：617 / 627
页数：10
相关论文
共 50 条
  • [21] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions
    de Kanter, Ruben
    Sidharta, Patricia N.
    Delahaye, Stphane
    Gnerre, Carmela
    Segrestaa, Jerome
    Buchmann, Stephan
    Kohl, Christopher
    Treiber, Alexander
    CLINICAL PHARMACOKINETICS, 2016, 55 (03) : 369 - 380
  • [22] Prediction of drug–drug interaction potential using physiologically based pharmacokinetic modeling
    Jee Sun Min
    Soo Kyung Bae
    Archives of Pharmacal Research, 2017, 40 : 1356 - 1379
  • [23] Assessment of OATP transporter-mediated drug-drug interaction using physiologically-based pharmacokinetic (PBPK) modeling - a case example
    Chen, Yuan
    Zhu, Rui
    Ma, Fang
    Mao, Jialin
    Chen, Eugene C.
    Choo, Edna F.
    Sahasranaman, Srikumar
    Liu, Lichuan
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (09) : 420 - 430
  • [24] Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions
    Burt, H. J.
    Neuhoff, S.
    Almond, L.
    Gaohua, L.
    Harwood, M. D.
    Jamei, M.
    Rostami-Hodjegan, A.
    Tucker, G. T.
    Rowland-Yeo, K.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 88 : 70 - 82
  • [25] Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
    Hannah Britz
    Nina Hanke
    Mitchell E. Taub
    Ting Wang
    Bhagwat Prasad
    Éric Fernandez
    Peter Stopfer
    Valerie Nock
    Thorsten Lehr
    Pharmaceutical Research, 2020, 37
  • [26] Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
    Britz, Hannah
    Hanke, Nina
    Taub, Mitchell E.
    Wang, Ting
    Prasad, Bhagwat
    Fernandez, Eric
    Stopfer, Peter
    Nock, Valerie
    Lehr, Thorsten
    PHARMACEUTICAL RESEARCH, 2020, 37 (12)
  • [27] Practical Assessment of Clinical Drug-Drug Interactions in Drug Development Using Physiologically Based Pharmacokinetics Modeling
    Shebley, Mohamad
    Einolf, Heidi J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (06) : 1326 - 1328
  • [28] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex
    Conner, Todd M.
    Nikolian, Vahagn C.
    Georgoff, Patrick E.
    Pai, Manjunath P.
    Alam, Hasan B.
    Sun, Duxin
    Reed, Ronald C.
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 111 : 465 - 481
  • [29] Physiologically based pharmacokinetic modeling of ponatinib to describe drug-drug interactions in patients with cancer
    Morita, Tomoko O.
    Hanada, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (04) : 315 - 323
  • [30] Physiologically Based Pharmacokinetic Modeling as a Tool to Predict Drug Interactions for Antibody-Drug Conjugates
    Yuan Chen
    Divya Samineni
    Sophie Mukadam
    Harvey Wong
    Ben-Quan Shen
    Dan Lu
    Sandhya Girish
    Cornelis Hop
    Jin Yan Jin
    Chunze Li
    Clinical Pharmacokinetics, 2015, 54 : 81 - 93
12345